Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
Authors:
- T.H. BourneTBT.H. Bourne
- W.P. CollinsWCW.P. Collins
- S. CampbellSCS. Campbell
- T.J. PowlesTPT.J. Powles
- S. AshleySAS. Ashley
- D.O. CosgroveDCD.O. Cosgrove
- 1 May 1994
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 343 (8909) , 1318-1321
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen‐associated endometrial polypsUltrasound in Obstetrics & Gynecology, 1994
- How safe is tamoxifen?BMJ, 1993
- Tamoxifen and the gynaecologistBJOG: An International Journal of Obstetrics & Gynaecology, 1993
- Tamoxifen and endometrial lesionsThe Lancet, 1993
- A Risk-Benefit Assessment of Tamoxifen TherapyDrug Safety, 1993
- Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.BMJ, 1993
- The case for clinical trials of tamoxifen for prevention of breast cancerThe Lancet, 1992
- Tamoxifen: disease prevention or disease substitution?The Lancet, 1992
- Detection of endometrial cancer by transvaginal ultrasonography with color flow imaging and blood flow analysis: A preliminary reportGynecologic Oncology, 1990
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer, 1990